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ABSTRACT
To study whether treatment with heparin (HEP) attenuates intestinal dysfunction caused
by ischemia (I) and reperfusion (R), rats were treated with HEP (100 U/kg intravenously)
or saline solution (SS) before I (60 min), which was produced by occlusion of the superior
mesenteric artery, and R (120 min). After I or I/R, we mounted 2-cm jejunal segment in
an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl,
using a digital recording system. Thin jejunal slices were stained with hematoxylin and
eosin for optical microscopy. Compared with the sham group, jejunal contractions were
similar in the IHEP and the I/RHEP groups, but reduced in the I SS and the I/R
SS groups. The jejunal enteric nerves were damaged in the I  SS and the I/R  SS, but
not in the I  HEP and the I/R  HEP cohorts. These results suggested that HEP
attenuated intestinal dysfunction caused by I and I/R.
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uIntestinal ischemia (I) and reperfusion (R) injuries occurin a variety of surgical practices, such as transplantation,
and critical illnesses, such as neonatal necrotizing entero-
colitis.1 The I and R injuries can lead to hypovolemia,
ypotension, hypoxia, and sepsis.1–3 They dramatically com-
promise motor and secretory functions of the intestine
owing to cellular lesions caused by deprivation of oxygen
and nutrients.1,2 In addition, vessels that suffer R after I can
experience many cellular lesions and death mainly owing to
lipid peroxidation of cell membranes caused by accumula-
tion of free oxygen radicals and other cytotoxic sub-
stances.2,3 In response to ischemia, cells undergo changes in
nzyme activities, mitochondrial functions, cytoskeletal
tructures, membrane transport, and antioxidant defenses,
hich collectively predispose to reoxygenation injury.2,3
The morphologic and functional injuries after I and R
remain a major challenge for patients undergoing trans-
plantation or major surgery.
The motor functions of mammalian intestines are regu-
lated by several excitatory and inhibitory transmitters which
are released from enteric nerves, including acetylcholine,
5=-triphosphate-adenosine (ATP), nitric oxide, neuropep-
tides, and other substances.4 The actions of these transmit-
ers are highly dependent on the integrity of the enteric
erves.5 However, intestinal motor activity is severely com-
promised in I/R mainly owing to a loss of structural and
functional integrity of the enteric nerves.5,6
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2300Several drugs have been proposed to attenuate or pre-
vent the structural and functional lesions caused by I and
R.7–12 Compounds such as heparin (HEP) and its derivates
may alter the activity of superoxide smutase (SOD), the
content of malondialdehyde (MDA), and the intracellular
Ca2 concentration. Some studies have suggested that HEP
and its derivatives, that are currently used as anticoagu-
lant and antithrombotic agents, act as free radical scaven-
gers and inhibitors of apoptosis in several cell types, pro-
tecting them from I/R lesions.17–22 Oxygen-derived free
adicals may be among the most important factors involved
n the I/R process.13,14 Because these radicals are highly
eactive, they immediately affect cellular membranes, which
onsist of polyunsaturated fatty acids, leading to lipid
eroxidation and generating potentially cytotoxic prod-
cts.13,14 Various pharmacologic agents, including allopuri-
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HEPARIN IN INTESTINAL ISCHEMIA AND REPERFUSION 2301nol ascorbic acid, have been evaluated to reduce free
radical levels in the ischemic process.15,16
Therefore, in the present work we investigated the effects
of HEP on the motility and histology of rat jejunal segments
undergoing intestinal I and R in rats.
MATERIALS AND METHODS
Male Wistar EPM-1 rats (270–300 g) were anesthetized with
ketamine (60 mg/kg) and xylazine (40 mg/kg), intravenously before
occlusion of the superior mesenteric artery with a metallic clip for
60 minutes of ischemia (I) followed by blood recirculation (R) for
120 minutes after removal of the clip. Twelve rats underwent only
I (I group) and 12 I and R (I/R group) in addition to a sham group
(n  6).
Among the I group, 6 rats were treated with saline solution
0.9% (SS) and 6 with HEP (100 mg/kgm) injected via the
femoral vein 5 minutes before I. In the I/R group, 6 rats weretreated with SS and 6 with HEP (100 mg/kg) injected via the
femoral vein 5 minute before 1 and 5 minutes before R as well
as 55 minutes after R.
After I or I/R, the rats were killed to obtain jejunal segments (2
cm) that were isolated, washed, cleared of surrounding tissues, and
mounted under 1 g tension at 37°C in an organ bath containing 10
mL aerated nutrient solution of composition (mmol/L) NaCl 138,
KCl 5.7, CaCl2 1.8, NaH2PO4 0.36, NaHCO3 15, and dextrose 5.5
pH 7.4). We studied neurogenic contractions induced by electrical
eld stimulation (EFS) or by the depolarizing agent KCl (70
mol/L) with the use of a digital recording system.6–8 EFS (5 and
0 Hz, 1 ms duration, 60 V) was performed by means of platinum
lectrodes connected to an S88 electrical stimulator (Grass,
SA).6–8 Responses to EFS and KCl were recorded by force-
isplacement transducers connected via a bridge amplifier to an
nalog/digital recording system (AD Instruments, USA). Data on
ontractile responses were subjected to statistical analysis using
-way analysis of variance and Student t test.7,8
Fig 1. Typical records of neu-
rogenic contractions induced
by electrical field stimulation (5
and 30 Hz) or KCl (70 mmol/L) in
jejunal segments of rats treated
with HEP or SS and submitted
to I or I/R. *Statistically different
from I  SS (P  .05; n  6);
#Statistically different from I/R 
SS (P  .05; n  6). HEP, hep-
arin; SS, saline solution; I, isch-
emia; R, reperfusion.
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2302 GHADIE, MIRANDA-FERREIRA, TAHA ET ALWe also performed histologic analyses using optical microscopy
of jejunal pieces embedded in paraffin, cut into thin slices, and
stained with hematoxylin and eosin.
RESULTS
Figure 1 shows that EFS (5 and 30 Hz) and KCl (70
mol/L) produced contractile responses in all jejunal seg-
ents: sham, I  SS, I  HEP, I/R  SS, I/R  HEP.
However, the amplitude of these contractions was similar in
I  HEP and IR  HEP groups but reduced in I  SS and
/R  SS groups compared with the sham group (Fig 1;
able 1).
Histologic analysis showed a loss of structural integrity of
nteric nerves in the jejunal segments of I/R  SS group
Fig 2B), but not in I/R  HEP (Fig 2C).
DISCUSSION
The complex mechanisms involving cellular death after I/R
insults are not fully understood. Significant increases in
tissues exposed to I/R have been observed in the content of
reactive oxygen species (ROS), such as hydroxyl radicals,
superoxide anions, and hydrogen peroxide, associated with
decreased antioxidant enzyme activities. ROS play a major
role in the pathophysiology of the ischemic injury via
oxidative damage to membrane lipids and proteins.15,16
Fig 2. Histologic aspects of jejuna of sham rat. (A) without isc
eparin andsubmitted to intestinal ischemia and/or reperfusion.
Table 1. Values of Amplitude of Neurogenic Contractions
(expressed in grams of tension) Induced by EFS (5 and 30 Hz)
or KCl (70 mmol/L) in Jejuna of Rats Treated with HEP or SS
and Submitted to Intestinal I or I/R
Groups 5 Hz 30 Hz KCl
Sham 1.43  0.12 2.15  0.19 2.25  0.18
 SS 0.18  0.04 0.28  0.05 0.41  0.10
I  HEP 0.73  0.10* 0.91  0.15* 1.26  0.14*
I/R  SS 0.18  0.06 0.45  0.10 0.61  0.17
I/R  HEP 0.56  0.07# 0.98  0.13# 1.21  0.18#
Data presented as mean  SEM (n  6).
Statistically different from sham (P  .05).
*Statistically different from I  SS (P  .05).
#Statistically different from I/R  SS (P  .05).nd enteric nerves (arrows). (Hematoxylin and eosin stain, 400).SOD represents the first line of defense against oxidative
stress, by catalyzing the dismutation reaction of superoxide
anion to hydrogen peroxide.17 MDA, one of the major
roducts of lipid peroxidation, has been extensively mea-
ured as an index of lipid peroxidation.18 Calcium is an
mportant second messenger in signal transduction and
eurotransmitter release. A sustained increase of Ca2
destabilizes the neuronal cytoarchitecture, resulting in cell
damage and eventual death. Ca2 enters neurons via
MDA- and AMPA-receptor–operated channels, voltage-
ated Ca2 channels, store-operated channels, and the
reverse operation of the Na/Ca2 exchanger. Addition-
ally, release from the organelles, such as endoplasmic
reticulum, mitochondria, and synaptic vesicles, as well as
from Ca2-binding proteins further increase intracellular
a2 levels. Thrombin also induces Ca2 transients and
subsequent nitric oxide (NO) production in vascular endo-
thelial cells. Thrombin cleaves protease-activated receptors
resulting in activation of intracellular signals.29
Calcium plays a unique role in the pathophysiology of
ischemia, because it causes several damaging events by
activating a variety of Ca2-dependent enzymes, including
rotein kinase C, phospholipase A2, phospholipase C,
yclooxygenase, calcium-dependent nitric oxide synthase,
nd calpain, as well as various proteases and endonucleases.
s a result of the formation of cytotoxic products, such as
ree radicals and leukotrienes, excess intracellular Ca2
triggers irreversible mitochondrial damage, inflammation,
and necrotic or programmed cell death.19
HEP and its derivatives have long been proposed for stroke
treatment. HEP may prevent venous thromboembolic compli-
cations, improve neurologic outcomes, reduce mortality, and
prevent early recurrence. Unfortunately, only the first objec-
tive has been confirmed.19,20 Low-molecular-weight HEP
(LMWH), which is obtained by depolymerization of stan-
dard HEP, was designed to reduce the risk of hemorrhage.
Compared with the parent compound, it shows substantial
advantages owing to greater bioavailability, longer half-life,
and reduced interaction with platelets, so it is supplanting
a and/or reperfusion, and treated with (B) saline solution or (C)
mages show the longitudinal muscle (ME), circular muscle (MI),hemi
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HEPARIN IN INTESTINAL ISCHEMIA AND REPERFUSION 2303HEP for various clinical indications. Some LMWH, includ-
ing nadroparin, danaparoid, certoparin, and tinzaparin, has
been tested in the treatment of acute I/R lesions.21–27
However, follow-up studies have failed to replicate the
results. Ultra-LMWH confers a much lower risk of bleed-
ing. It can penetrate the blood-brain barrier, so it may be a
safe, effective drug for the treatment of acute ischemic
strokes.
In the present study, we investigated the effect of HEP in
an animal model of I/R using portal vein and hepatic artery
occlusion. HEP attenuated hepatic lesions caused by I/R in
rabbits. Studying hepatic I/R, Taha et al. (2009) observed
HEP to produce protective effects on rabbits by controlling
levels of aspartate aminotransferase, alanine aminotrans-
ferase, and lactate dehydrogenase. In addition, histologic
analysis showed significant reductions in lesions caused by
I/R among livers of HEP-treated rabbits.28
Celik et al. (2009) demonstrated that HEP reduced flap
necrosis and improved survival owing to radical scavenging,
antioxidant effects, and supportive activities on capillary
permeability and transudation.30 More recently, Medeiros
t al (2001) showed that heparin also induced intracellular
alcium release, activation of phospholipase C and of
alcium calmodulin kinase II, and increased NO produc-
ion,31 protective factors on vessels during I and R.
In conclusion, HEP produced protection on jejunal seg-
ments that had suffered I/R lesions.
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